Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: Does effectiveness offset the teratogenic risks?
Sign Up to like & getrecommendations! Published in 2024 at "Epilepsia"
DOI: 10.1111/epi.17892
Abstract: Regulatory agencies have recently discouraged the prescription of topiramate (TPM) to women of childbearing potential with epilepsy due to growing evidence of the teratogenic and neurodevelopmental risks associated with its use during pregnancy. It remains,… read more here.
Keywords: potential idiopathic; idiopathic generalized; childbearing potential; epilepsy ... See more keywords